ALVO Alvotech

NEUTRAL Impact: 2/10 PRESS-RELEASE
Horizon days Filed Apr 24, 2026 Processed 1mo ago Wire GlobeNewswire
Press release: announcement
Latest settled — T+20d ⚠ clustered
ALVO ▲ 0.00% at T+20d
NEUTRAL call ✗ call lost 0.00% · α vs SPY -4.03% · entry $3.38 → $3.38
Next anchor: T+60d in 5w
Last close $4.17 (close Jun 12) · +23.37% from $3.38 entry
Entry anchored
Apr 23, 03:59 PM ET
via Databento tick
T+1d
-2.37%
call -2.37% · α -2.53%
$3.30
settled 7w ago
T+5d
-1.18%
call -1.18% · α -2.09%
$3.34
settled 6w ago
T+20d
0.00%
call 0.00% · α -4.03%
$3.38
settled 24d ago
T+60d
call — · α —
in 5w

Price Chart

Loading chart...

Executive Summary

Alvotech announced it will release its Q1 2026 financial results on May 6, 2026, followed by a webcast and live Q&A on May 7, 2026. The press release is purely logistical, confirming the earnings date and call details without disclosing any financial data or updates. This type of announcement is routine and provides no new material information.

Actionable Insight

Traders should monitor the May 6 earnings release and May 7 call for updates on revenue, R&D progress, and commercial performance of Alvotech’s biosimilar pipeline. The lack of pre-disclosed data means volatility is likely to be driven by actual results and management commentary during the call.

Key Facts

  • Alvotech will release Q1 2026 financial results on May 6, 2026, after market close.
  • A webcast with live Q&A is scheduled for May 7, 2026, at 08:00 EST.
  • No financial results, guidance updates, or operational developments were disclosed in this release.
  • The announcement serves only to communicate timing and access details for the upcoming earnings call.

Financial Impact

None disclosed — this is a scheduling announcement only.

Risk Factors

  • Potential for negative earnings surprise or weak guidance during the upcoming call.
  • Lack of near-term catalysts outside of earnings, which may lead to investor sentiment fatigue.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
75% bullish (12 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3280780
10 reports for ALVO
Performance horizon
50% Hit rate 2 of 4 directional calls best @ T+20▲ +1.88%May 6, 2026
Filters
Rows
Reports for ALVO — sortable, filterable
Type Now
Jun 8, 2026
7d ago
Press Release
NEUTRAL ★ 4/10
$3.55 awaiting T+1awaiting T+1$4.17 (+17.63%)
Jun 8, 2026
7d ago
Press Release
NEUTRAL ★ 4/10
$3.55 awaiting T+1awaiting T+1$4.17 (+17.63%)
Jun 4, 2026
11d ago
Press Release
BULLISH ★ 7/10
$3.74 $3.54▼ −5.35%▼ −2.75%$4.17 (+11.50%)
May 11, 2026
5w ago
Press Release
NEUTRAL ★ 4/10
$3.59 $3.55▼ −1.11%▼ −0.98%$4.17 (+16.16%)
May 11, 2026
5w ago
Press Release
BULLISH ★ 6/10
$3.59 $3.55▼ −1.11%▼ −0.98%$4.17 (+16.16%)
May 6, 2026
5w ago
Press Release
BEARISH ★ 7/10
$3.20 $3.20· 0.00%▲ +0.83%$4.17 (−30.31%)
May 6, 2026
5w ago
Press Release
BEARISH ★ 6/10
$3.20 $3.20· 0.00%▲ +0.83%$4.17 (−30.31%)
Apr 24, 2026
7w ago
Press Release
NEUTRAL ★ 2/10
$3.38 $3.30▼ −2.37%▼ −2.53%$4.17 (+23.37%)
Apr 24, 2026
7w ago
Press Release
NEUTRAL ★ 3/10
$3.38 $3.30▼ −2.37%▼ −2.53%$4.17 (+23.37%)
Mar 4, 2026
14w ago
Press Release
NEUTRAL ★ 3/10
$3.89 $4.16▲ +6.94%▲ +7.51%$4.17 (+7.20%)
Showing 10 of 10

US Market Status

Market Closed — Opens in 4h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access